229 related articles for article (PubMed ID: 34031692)
41. Early COVID-19 First-Dose Vaccination Coverage Among Residents and Staff Members of Skilled Nursing Facilities Participating in the Pharmacy Partnership for Long-Term Care Program - United States, December 2020-January 2021.
Gharpure R; Guo A; Bishnoi CK; Patel U; Gifford D; Tippins A; Jaffe A; Shulman E; Stone N; Mungai E; Bagchi S; Bell J; Srinivasan A; Patel A; Link-Gelles R
MMWR Morb Mortal Wkly Rep; 2021 Feb; 70(5):178-182. PubMed ID: 33539332
[TBL] [Abstract][Full Text] [Related]
42. Investigation of a Severe Acute Respiratory Syndrome Coronavirus 2 Delta (B.1.617.2) Variant Outbreak Among Residents of a Skilled Nursing Facility and Vaccine Effectiveness Analysis: Maricopa County, Arizona, June-July 2021.
Dale AP; Almendares O; Howard BJ; Burnett E; Prasai S; Arons M; Collins J; Duffy N; Pandit U; Brady S; White JR; Garrett B; Kirking HL; Sunenshine R; Tate JE; Scott SE
Clin Infect Dis; 2022 Aug; 75(1):e20-e26. PubMed ID: 35413107
[TBL] [Abstract][Full Text] [Related]
43. Antibody Seroprevalence, Infection and Surveillance for SARS-CoV-2 in Residents and Staff of New Jersey Long-Term Care Facilities.
Friedman SM; Davidow AL; Gurumurthy M; Peymani R; Webb J; Desai K; Siderits R; Nepomich A; Lifshitz E; Thomas PA
J Community Health; 2022 Oct; 47(5):774-782. PubMed ID: 35704225
[TBL] [Abstract][Full Text] [Related]
44. Association between SARS-CoV-2 Seroprevalence in Nursing Home Staff and Resident COVID-19 Cases and Mortality: A Cross-Sectional Study.
Wisniak A; Menon LK; Dumont R; Pullen N; Regard S; Dubos R; Zaballa ME; Baysson H; Courvoisier D; Kaiser L; Pittet D; Azman AS; Stringhini S; Guessous I; Balavoine JF; Kherad O; The SEROCoV-Work Study Group
Viruses; 2021 Dec; 14(1):. PubMed ID: 35062247
[TBL] [Abstract][Full Text] [Related]
45. Detection of SARS-CoV-2 Among Residents and Staff Members of an Independent and Assisted Living Community for Older Adults - Seattle, Washington, 2020.
Roxby AC; Greninger AL; Hatfield KM; Lynch JB; Dellit TH; James A; Taylor J; Page LC; Kimball A; Arons M; Schieve LA; Munanga A; Stone N; Jernigan JA; Reddy SC; Lewis J; Cohen SA; Jerome KR; Duchin JS; Neme S
MMWR Morb Mortal Wkly Rep; 2020 Apr; 69(14):416-418. PubMed ID: 32271726
[TBL] [Abstract][Full Text] [Related]
46. Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.
Bajema KL; Wiegand RE; Cuffe K; Patel SV; Iachan R; Lim T; Lee A; Moyse D; Havers FP; Harding L; Fry AM; Hall AJ; Martin K; Biel M; Deng Y; Meyer WA; Mathur M; Kyle T; Gundlapalli AV; Thornburg NJ; Petersen LR; Edens C
JAMA Intern Med; 2021 Apr; 181(4):450-460. PubMed ID: 33231628
[TBL] [Abstract][Full Text] [Related]
47. Probability-Based Estimates of Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence and Detection Fraction, Utah, USA.
Samore MH; Looney A; Orleans B; Greene T; Seegert N; Delgado JC; Presson A; Zhang C; Ying J; Zhang Y; Shen J; Slev P; Gaulin M; Yang MJ; Pavia AT; Alder SC
Emerg Infect Dis; 2021 Nov; 27(11):2786-2794. PubMed ID: 34469285
[TBL] [Abstract][Full Text] [Related]
48. Seroprevalence of SARS-CoV-2 among the staff and patients of a French cancer centre after first lockdown: The canSEROcov study.
Ladoire S; Goussot V; Redersdorff E; Cueff A; Ballot E; Truntzer C; Ayati S; Bengrine-Lefevre L; Bremaud N; Coudert B; Desmoulins I; Favier L; Fraisse C; Fumet JD; Hanu R; Hennequin A; Hervieu A; Ilie S; Kaderbhai C; Lagrange A; Martin N; Mazilu I; Mayeur D; Palmier R; Simonet-Lamm AL; Vincent J; Zanetta S; Arnould L; Coutant C; Bertaut A; Ghiringhelli F
Eur J Cancer; 2021 May; 148():359-370. PubMed ID: 33780664
[TBL] [Abstract][Full Text] [Related]
49. Antibody response using six different serological assays in a completely PCR-tested community after a coronavirus disease 2019 outbreak-the CoNAN study.
Weis S; Scherag A; Baier M; Kiehntopf M; Kamradt T; Kolanos S; Ankert J; Glöckner S; Makarewicz O; Hagel S; Bahrs C; Kimmig A; Proquitté H; Guerra J; Rimek D; Löffler B; Pletz MW;
Clin Microbiol Infect; 2021 Mar; 27(3):470.e1-470.e9. PubMed ID: 33221432
[TBL] [Abstract][Full Text] [Related]
50. Diagnosed and Undiagnosed COVID-19 in US Emergency Department Health Care Personnel: A Cross-sectional Analysis.
Mohr NM; Harland KK; Krishnadasan A; Eyck PT; Mower WR; Willey J; Chisolm-Straker M; Lim SC; McDonald LC; Kutty PK; Hesse E; Santibanez S; Talan DA;
Ann Emerg Med; 2021 Jul; 78(1):27-34. PubMed ID: 33771413
[TBL] [Abstract][Full Text] [Related]
51. Mass testing after a single suspected or confirmed case of COVID-19 in London care homes, April-May 2020: implications for policy and practice.
Tang S; Sanchez Perez M; Saavedra-Campos M; Paranthaman K; Myers R; Fok J; Crawley-Boevey E; Dun-Campbell K; Janarthanan R; Fernandez E; Vusirikala A; Patel B; Ma T; Amin-Chowdhury Z; Shetty N; Zambon M; Bell A; Wynne-Evans E; Chow Y; Ladhani S
Age Ageing; 2021 May; 50(3):649-656. PubMed ID: 33620453
[TBL] [Abstract][Full Text] [Related]
52. A Study of Universal Severe Acute Respiratory Syndrome Coronavirus 2 RNA Testing Among Residents and Staff in a Large Group of Care Homes in South London.
Marossy A; Rakowicz S; Bhan A; Noon S; Rees A; Virk M; Nazafi A; Hay E; de Thomasson L; Windle C; Zuckerman M
J Infect Dis; 2021 Feb; 223(3):381-388. PubMed ID: 32889532
[TBL] [Abstract][Full Text] [Related]
53. Cross-Sectional Analysis of Risk Factors for Outbreak of COVID-19 in Nursing Homes for Older Adults in the Community of Madrid.
San Román J; Candel FJ; Del Mar Carretero M; Sanz JC; Pérez-Abeledo M; Barreiro P; Viñuela-Prieto JM; Ramos B; Canora J; Barba R; Zapatero A; Martínez-Peromingo FJ;
Gerontology; 2023; 69(2):163-171. PubMed ID: 35654010
[TBL] [Abstract][Full Text] [Related]
54. SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurvey.
Murhekar MV; Bhatnagar T; Selvaraju S; Saravanakumar V; Thangaraj JWV; Shah N; Kumar MS; Rade K; Sabarinathan R; Asthana S; Balachandar R; Bangar SD; Bansal AK; Bhat J; Chopra V; Das D; Deb AK; Devi KR; Dwivedi GR; Khan SMS; Kumar CPG; Kumar MS; Laxmaiah A; Madhukar M; Mahapatra A; Mohanty SS; Rangaraju C; Turuk A; Baradwaj DK; Chahal AS; Debnath F; Haq I; Kalliath A; Kanungo S; Kshatri JS; Lakshmi GGJN; Mitra A; Nirmala AR; Prasad GV; Qurieshi MA; Sahay S; Sangwan RK; Sekar K; Shukla VK; Singh PK; Singh P; Singh R; Varma DS; Viramgami A; Panda S; Reddy DCS; Bhargava B;
Lancet Glob Health; 2021 Mar; 9(3):e257-e266. PubMed ID: 33515512
[TBL] [Abstract][Full Text] [Related]
55. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in the staff of a public school system in the midwestern United States.
Lopez L; Nguyen T; Weber G; Kleimola K; Bereda M; Liu Y; Accorsi EK; Skates SJ; Santa Maria JP; Smith KR; Kalinich M
PLoS One; 2021; 16(6):e0243676. PubMed ID: 34111144
[TBL] [Abstract][Full Text] [Related]
56. Prevalence of COVID-19 IgG Antibodies in a Cohort of Municipal First Responders.
McGuire SS; Klassen AB; Heywood J; Sztajnkrycer MD
Prehosp Disaster Med; 2021 Apr; 36(2):131-134. PubMed ID: 33397545
[TBL] [Abstract][Full Text] [Related]
57. Epidemiologic, Immunologic, and Virus Characteristics in Patients With Paired Severe Acute Respiratory Syndrome Coronavirus 2 Serology and Reverse-Transcription Polymerase Chain Reaction Testing.
Shragai T; Smith-Jeffcoat SE; Koh M; Schechter MC; Rebolledo PA; Kasinathan V; Wang Y; Hoffman A; Miller H; Tejada-Strop A; Jain S; Tamin A; Harcourt JL; Thornburg NJ; Wong P; Medrzycki M; Folster JM; Semenova V; Steward-Clark E; Drobenuic J; Biedron C; Stewart RJ; da Silva J; Kirking HL; Tate JE;
J Infect Dis; 2022 Jan; 225(2):229-237. PubMed ID: 34216468
[TBL] [Abstract][Full Text] [Related]
58. Prevalence of SARS-CoV-2 infection and dynamics of antibodies response among previously undiagnosed healthcare workers in a university hospital: A prospective cohort study.
Musa S; Abdel Alem S; Amer K; Elnagdy T; Hassan WA; Ali MA; Gaber Y; Badary HA; Tantawi O; Abdelmoniem R; Radwan A; Yousof H; Shawky S; Talaat H; Fouad R; Kassem AM
J Infect Public Health; 2021 Oct; 14(10):1466-1473. PubMed ID: 34175238
[TBL] [Abstract][Full Text] [Related]
59. Provider Antibody Serology Study of Virus in the Emergency Room (PASSOVER) Study: Special Population COVID-19 Seroprevalence.
Heyming TW; Sanger T; Tongol A; Schomberg J; Bacon K; Lara B
West J Emerg Med; 2021 Apr; 22(3):565-571. PubMed ID: 34125028
[TBL] [Abstract][Full Text] [Related]
60. Seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection among Veterans Affairs healthcare system employees suggests higher risk of infection when exposed to SARS-CoV-2 outside the work environment.
Dimcheff DE; Schildhouse RJ; Hausman MS; Vincent BM; Markovitz E; Chensue SW; Deng J; McLeod M; Hagan D; Russell J; Bradley SF
Infect Control Hosp Epidemiol; 2021 Apr; 42(4):392-398. PubMed ID: 32962771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
